Pharmaceutical Research & Development

Our Drug Pipeline

Our drug research and development pipeline

Our product pipeline reflects our commitment to developing innovative products that help diagnose or treat gastrointestinal disorders. By focusing on late-stage products and investigating currently marketed products for new indications, we are able to focus on drugs with a record of safety and efficacy. This page features information on the compounds currently in our pipeline. Click the study ID number below to learn more about our clinical trials.


DRUG, INDICATION, & STUDY ID NUMBER PHASE 1 PHASE 2 PHASE 3 FILED
Rifaximin
Irritable bowel syndrome*
RFIB3007 RFIB3008
Budesonide foam
Ulcerative colitis
BUCF3001 BUCF3002
 
Crofelemer
Secretory diarrhea
NP303-101
 
Hexaminolevulinate
Colon cancer detection
PCCO101/05
     
*Received complete response letter from FDA. View press release.
Check out our latest Press Releases and News Request a Media Relations Kit Order an Investor Relations Kit
Salix Pharmaceuticals on Facebook   Salix Pharmaceuticals on Twitter